Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (343)
Article
How Evernorth's Clinical Trials team connects people to potentially lifesaving treatments
August 09, 2023
We sat down with Ria Westergaard, director of product innovation and a pharmacist who leads Evernorth's Clinical Trials team, to better understand the work her team does and how it improves patient ou...
Newsroom
Express Scripts Names Head of Independent Pharmacy Affairs to Deepen Partnerships, Expand Access to Care
August 08, 2023
Dr. Stephanie Smith Cooney will establish Express Scripts’ Office of Independent Pharmacy Enablement and lead the industry’s first Independent Pharmacy Advisory Committee
Newsroom
MDLIVE Intergenerational Study Shows Mental Health of American Families At-Risk
August 09, 2023
Article
The Lab by Evernorth: Turning data into insights to improve the health and vitality of those we serve
November 02, 2023
Article
Gene therapies: Million-dollar miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreArticle
The importance of utilization management within the medical benefit
August 17, 2023
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Report
Study: Cardiodiabesity prevention key to improving health outcomes and lowering costs
November 25, 2024
The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardi...
Article
Improving access to care for rural Americans by supporting and empowering independent pharmacies
We sat down with Adam Kautzner, a pharmacist and the president of Express Scripts, who discussed some of our recent endeavors to improve access to quality care in rural America.
Read MoreArticle
Boosting Biosimilars Competition and Savings
September 25, 2023
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Article
Designing plans to manage comorbid conditions
August 25, 2023
Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.